Back to User profile » Dr James E Herndon II
Paper published by Dr James E Herndon II:
Original Research
A Phase II single-arm trial of palonosetron for the prevention of acute and delayed chemotherapy-induced nausea and vomiting in malignant glioma patients receiving multidose irinotecan in combination with bevacizumab
Affronti ML, Woodring S, Peters KB, Herndon II JE, McSherry F, Healy PN, Desjardins A, Vredenburgh JJ, Friedman HS
Therapeutics and Clinical Risk Management 2017, 13:33-40
Published Date: 23 December 2016